Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study

Pediatric Blood and Cancer

Volumn 64, Issue 4, 2017, Pages

  Xu, Xiao Jun ^a   Wang, Hong Sheng ^b   Ju, Xiu Li ^c   Xiao, Pei Fang ^d   Xiao, Yan ^e   Xue, Hong Man ^f   Shi, Hong Yu ^g   Gao, Yi Jin ^h   Jia, Guo Cun ⁱ   Li, Xue Rong ^j   Zhao, Wei Hong ^k   Wang, Ning Ling ^l   Tang, Yong Min ^a  

^a CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

^d CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^e UNION HOSPITAL   (China)

^f SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^g Children's Hospital of Shanxi   (China)

^h SHANGHAI CHILDREN S MEDICAL CENTER   (China)

ⁱ Department of Nuclear Medicine   (China)

^j QINGDAO UNIVERSITY   (China)

^k PEKING UNIVERSITY FIRST HOSPITAL   (China)

^l ANHUI MEDICAL UNIVERSITY   (China)

more..

Author keywords

child; China; hemophagocytic lymphohistiocytosis; outcome

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; ETOPOSIDE; IMMUNOGLOBULIN; BIOLOGICAL MARKER; LYST PROTEIN, HUMAN; MEMBRANE PROTEIN; MUNC18 PROTEIN; PERFORIN; PRF1 PROTEIN, HUMAN; STXBP2 PROTEIN, HUMAN; UNC13D PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

ADOLESCENT; ARTICLE; CHILD; CHINA; CLINICAL FEATURE; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; HEMOPHAGOCYTIC SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TREATMENT OUTCOME; CLINICAL TRIAL; COMBINATION DRUG THERAPY; FOLLOW UP; GENETICS; INFANT; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; METABOLISM; MULTICENTER STUDY; MUTATION; NEWBORN; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; BIOMARKERS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MEMBRANE PROTEINS; MUNC18 PROTEINS; MUTATION; PERFORIN; PROGNOSIS; RETROSPECTIVE STUDIES; VESICULAR TRANSPORT PROTEINS;

EID: 84999885251     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.26264     Document Type: Article

References (20)

1. Tang YM, Xu XJ. Advances in hemophagocytic lymphohistiocytosis: pathogenesis, early diagnosis/differential diagnosis, and treatment. Scientific World Journal. 2011;11:697–708.
2. Henter JI, Elinder G, Soder O, et al. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood. 1991;78:2918–2922.
3. Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistiocytosis: advances in pathophysiology, diagnosis, and treatment. J Pediatr. 2013;163:1253–1259.
4. Bode SF, Ammann S, Al-Herz W, et al. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis. Haematologica. 2015;100:978–988.
5. Henter JI, Horne A, Arico M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–131.
6. Henter JI, Arico M, Egeler RM, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol. 1997;28:342–347.
7. Xu XJ, Tang YM, Song H, et al. Diagnostic accuracy of a specific cytokine pattern in hemophagocytic lymphohistiocytosis in children. J Pediatr. 2012;160:984–990 e981.
8. Koh KN, Im HJ, Chung NG, et al. Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party. Eur J Haematol. 2015;94:51–59.
9. Kogawa K, Sato H, Asano T, et al. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group. Pediatr Blood Cancer. 2014;61:1257–1262.
10. Trottestam H, Horne A, Arico M, et al. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol. Blood. 2011;118:4577–4584.
11. Trottestam H, Berglof E, Horne A, et al. Risk factors for early death in children with haemophagocytic lymphohistiocytosis. Acta Paediatr. 2012;101:313–318.
12. Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007;86:58–65.
13. Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients. Medicine (Baltimore). 2014;93:100–105.
14. Yang S, Zhang L, Jia C, et al. Frequency and development of CNS involvement in Chinese children with hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2010;54:408–415.
15. Xiao L, Guan X, Meng Y, et al. Analysis of clinical and laboratory features of 217 pediatric hemophagocytic lymphohistiocytosis [in Chinese]. Zhonghua Xue Ye Xue Za Zhi. 2014;35:628–632.
16. Zhizhuo H, Junmei X, Yuelin S, et al. Screening the PRF1, UNC13D, STX11, SH2D1A, XIAP, and ITK gene mutations in Chinese children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2012;58:410–414.
17. Zhang K, Chandrakasan S, Chapman H, et al. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood. 2014;124:1331–1334.
18. Lin TF, Ferlic-Stark LL, Allen CE, Kozinetz CA, McClain KL. Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality. Pediatr Blood Cancer. 2011;56:154–155.
19. Lehmberg K, McClain KL, Janka GE, Allen CE. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2014;61:2101–2103.
20. Saeed H, Woods RR, Lester J, et al. Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting. Int J Hematol. 2015;102:195–199.